Treatment approaches in relapsed or refractory peripheral T-cell lymphomas [version 1; peer review: 3 approved]
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare and aggressive non-Hodgkin’s lymphomas. Clinical staging, prognostic scoring, and initial treatment strategies have historically been based on paradigms developed in B-cell lymphomas. Despite primary treatment protocols that are t...
Main Authors: | Cheryl Foster, John Kuruvilla |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-09-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-1091/v1 |
Similar Items
-
Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
by: Makita S, et al.
Published: (2018-04-01) -
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
by: Bodiford A, et al.
Published: (2014-10-01) -
TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA
by: E. A. Baryakh
Published: (2017-06-01) -
Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children
by: NS Kulichkina, et al.
Published: (2016-01-01) -
Safety and Efficacy of Pralatrexate in the Management of Relapsed or Refractory Peripheral T-cell Lymphoma
by: Annabelle L. Rodd, et al.
Published: (2012-01-01)